Skip to main content

Table 2 Patient demographics

From: When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation

Characteristic

 

Overall

N = 20

US

N = 14

Switzerland

N = 6

Gender (n)

Female

10

8

2

Male

10

6

4

Age (years)

Mean

64.0

61.6

69.8

Min-Max

46–80

46–80

65–75

Race (n)

White

13

13

N/Aa

Multiracial

1

1

N/Aa

Ethnicity (n)

Not Hispanic or Latino

12

12

N/Aa

Hispanic/Latino

2

2

N/Aa

Highest level of education (n)

Some high school

0

0

0

Completed high school

8

4

4

Some college

8

8

0

Bachelor’s degree

3

1

2

Not listed

1

1

0

Work status (n)

Full-time

7

7

0

Part-time

1

1

0

Disabled

1

1

0

Retired

11

5

6

Time since T2D diagnosis (years)

Mean

17.4

16.7

19.3

Min-Max

6.5–31

6.5–26

13–31

Time since first basal insulin treatment (years)

Mean

5.3

4.9

6.2

Min-Max

0.5–18

0.5–18

3–13.5

Time since IDeg start (years)

Mean

1.1

0.6

2.4

Min-Max

< 0.5–3

< 0.5–1

1.5–3

  1. a Race and ethnicity not collected in Switzerland for cultural reasons
  2. IDeg, insulin degludec